aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Rapha Capital Management specializes in identifying and investing in revolutionary ideas within medicine, healthcare, and technology sectors. The firm focuses on early-stage opportunities, particularly in Series A and Convertible Note rounds, with occasional participation in later stages such as Series C.
Notable portfolio companies include AsclepiX Therapeutics, which has raised $50 million for innovative ophthalmology treatments, and Poseida Therapeutics, with $142 million raised for cell and gene therapies. Rapha Capital Management's investment philosophy centers on recognizing transformative potential in healthcare and biotech innovations before they become widely apparent to other investors.
Also Known As
Rapha Capital Management, Llc.
Operating Status
Active
Rapha Capital Management Address
Surfside,
Florida
33154
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts